These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18586401)

  • 1. SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice.
    Takahashi K; Ishida M; Komano H; Takahashi H
    Neurosci Lett; 2008 Aug; 441(1):90-3. PubMed ID: 18586401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice].
    Zhao XY; Wang DD; Shan Y; Zhu CQ
    Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J; Ittner LM; Kins S
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus Tau (P301S) expression in adult amyloid precursor protein (APP)-transgenic mice leads to tangle formation.
    Osinde M; Clavaguera F; May-Nass R; Tolnay M; Dev KK
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):523-31. PubMed ID: 18282162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.
    Eckert A; Hauptmann S; Scherping I; Rhein V; Müller-Spahn F; Götz J; Müller WE
    Neurodegener Dis; 2008; 5(3-4):157-9. PubMed ID: 18322377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse.
    Oikawa N; Ogino K; Masumoto T; Yamaguchi H; Yanagisawa K
    Neurosci Lett; 2010 Jan; 468(3):243-7. PubMed ID: 19900506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal processing of tau in the brain of aged TgCRND8 mice.
    Bellucci A; Rosi MC; Grossi C; Fiorentini A; Luccarini I; Casamenti F
    Neurobiol Dis; 2007 Sep; 27(3):328-38. PubMed ID: 17656099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel increase in p70 kinase activation and tau phosphorylation (S262) with Abeta overproduction.
    Zhou XW; Tanila H; Pei JJ
    FEBS Lett; 2008 Jan; 582(2):159-64. PubMed ID: 18068129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.
    Stamer K; Vogel R; Thies E; Mandelkow E; Mandelkow EM
    J Cell Biol; 2002 Mar; 156(6):1051-63. PubMed ID: 11901170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.
    Rosi MC; Luccarini I; Grossi C; Fiorentini A; Spillantini MG; Prisco A; Scali C; Gianfriddo M; Caricasole A; Terstappen GC; Casamenti F
    J Neurochem; 2010 Mar; 112(6):1539-51. PubMed ID: 20050968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
    Deters N; Ittner LM; Götz J
    Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.